Fraietta, Joseph A.
Nobles, Christopher L.
Sammons, Morgan A.
Lundh, Stefan
Carty, Shannon A.
Reich, Tyler J.
Cogdill, Alexandria P.
Morrissette, Jennifer J. D.
DeNizio, Jamie E.
Reddy, Shantan
Hwang, Young
Gohil, Mercy
Kulikovskaya, Irina
Nazimuddin, Farzana
Gupta, Minnal
Chen, Fang
Everett, John K.
Alexander, Katherine A.
Lin-Shiao, Enrique
Gee, Marvin H.
Liu, Xiaojun
Young, Regina M.
Ambrose, David
Wang, Yan
Xu, Jun
Jordan, Martha S.
Marcucci, Katherine T.
Levine, Bruce L.
Garcia, K. Christopher
Zhao, Yangbing
Kalos, Michael
Porter, David L.
Kohli, Rahul M.
Lacey, Simon F.
Berger, Shelley L.
Bushman, Frederic D.
June, Carl H.
Melenhorst, J. Joseph
Article History
Received: 19 February 2017
Accepted: 27 April 2018
First Online: 30 May 2018
Competing interests
: J.A.F., C.L.N., R.M.Y., B.L.L., M.K., D.L.P., S.F.L., F.D.B., C.H.J. and J.J.M. hold patents related to CTL019 cell therapy. These authors declare no additional competing interests. The remaining authors declare no competing interests.